# Wang Jie

> Wang Jie is a Series A investor in China backing Health Care and Biotechnology. See 1 investments, round sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Location: China
- Total investments: 1
- Last investment: Mar 2014
- Lead investor: 0%
- Last updated: Oct 2026

Wang Jie is a Series A investor in China focused on Health Care and Biotechnology. Co-founder of SyMap Medical.Dr. Wang is an established and a well known expert in cardiovascular research and the industry. He was the pioneer to introduce biotechnology and biopharmaceuticals into China, funded and led three companies in China to manufacture recombinant protein drugs and interventional cardiology devices, respectively. Dr. Wang has served as a consultant to a number of the world’s largest pharmaceutical companies, venture capital firms, start-up companies and consulting firms. He guided key animal experiments and first-in-human studies in China to prove the concept of Ardian’s renal denervation therapy for hypertension, heart failure and other cardiovascular diseases. He has been awarded “CRT 2012 Best Innovation Award” due to his patents of renal sympathetic nerve mapping/ablation devices. His leadership in both academia and industry has been demonstrated by his extraordinary carrier path: an associate professor at Columbia University, the Dean of Medical School of Nanjing University, Associate Director of the Skirball Center for Cardiovascular Research, Executive Vice President of Institute of Clinical and Translational Research/Jiangsu Province Hospital, and a co-founder of SyMap Medical Ltd (Approved for “Fast Track” by CFDA; invested by Sequoia and Softbank).

## Contacts

5 contacts available for Wang Jie: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/wang-jie?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SyMap Medical | SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure. |  | Series A | Mar 18, 2014 | https://www.symapmedical.com |

1 of 1 investments shown.

## Co-investors
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 1 deal together
- [SBCVC](https://shizune.co/investors/profile/softbank-china-venture-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [SOSV SF & NY (Fka IndieBio)](https://shizune.co/investors/profile/synbio-axlr8r) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund

## Featured in investor lists
- [Biotechnology Angel Investors in China](https://shizune.co/investors/biotechnology-angel-investors-china)
- [Biotech Angel Investors in China](https://shizune.co/investors/biotech-angel-investors-china)

## FAQ

### What does Wang Jie invest in?

Wang Jie invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Wang Jie?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Wang Jie last invest?

The most recent investment recorded for Wang Jie closed in Mar 2014. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co